ANAL MARGIN SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL MARGIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL MARGIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL MARGIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests if boosting immune system can stop anal Cancer's return
Disease control OngoingThis large, late-stage trial is testing whether adding the immunotherapy drug nivolumab after standard chemoradiation treatment can help prevent cancer from returning in patients with high-risk anal cancer. The study involves 344 adults who have completed initial treatment. Parti…
Matched conditions: ANAL MARGIN SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
Study aims to tame anal cancer with less harsh treatment
Disease control OngoingThis study is testing whether a lower dose of chemotherapy combined with radiation works as well as the standard, stronger dose for treating early-stage anal cancer. It involves 252 adults with early-stage disease who have not spread to lymph nodes. The main goal is to see if the…
Matched conditions: ANAL MARGIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC